# Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital

> **NCT06681363** · — · NOT_YET_RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Acute Myeloid Leucemia
- High-risk Myelodysplastic Syndrome (MDS)
- Acute Lymphoid Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06681363
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-15
- **Primary completion:** 2036-06-15
- **Final completion:** 2036-06-15
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06681363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06681363, "Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06681363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*